Literature DB >> 26311166

Morning hypertension and night non-dipping in patients with diabetes and chronic kidney disease.

Se Won Oh1, Sang Youb Han1, Kum Hyun Han1, Ran-hui Cha2, Sejoong Kim3, Sun Ae Yoon4, Dong-Ryeol Rhu5, Jieun Oh6, Eun Young Lee7, Dong Ki Kim8, Yon Su Kim8,9.   

Abstract

Morning hypertension (HTN) and nocturnal non-dipping (ND) are closely associated with target organ damage and cardiovascular events. However, their importance in diabetics with advanced renal disease is unclear. We evaluated the relationships of morning HTN and ND with estimated glomerular filtration rate (eGFR) and proteinuria, and determined the risk of morning HTN and ND according to presence of diabetes mellitus (DM) and chronic kidney disease (CKD) stage. A total of 1312 patients, including 439 with diabetes, were prospectively recruited at 21 centers in Korea. All patients had HTN and an eGFR of 15-89 ml min(-1) per 1.73 m(2). Ambulatory 24-h blood pressure was assessed. The rates of morning HTN (25.2% vs. 13.6%, P<0.001) and ND (58.2% vs. 48.2%, P=0.002) were higher in diabetics than in non-diabetics. eGFR was correlated with ND in all patients (P<0.05) and with morning HTN only in non-diabetics (P=0.005). Proteinuria was related to ND in all patients (P<0.05) and to morning HTN only in diabetics (P=0.001). In a regression analysis, the risk of morning HTN was 2.093 (95% confidence interval (95% CI): 1.070-4.094) for the DMCKD2 group, 1.634 (95% CI: 1.044-2.557) for the CKD3-4-only group and 2.236 (95% CI: 1.401-3.570) for the DMCKD3-4 group compared with the CKD2-only group. The risk of ND was high for stage 3-4 CKD: 1.581 (95% CI: 1.180-2.120) for non-diabetics and 1.842 (95% CI: 1.348-2.601) for diabetics. Diabetics showed higher rates of morning HTN, ND and uncontrolled sustained HTN compared with non-diabetics with CKD of the same stages.

Entities:  

Mesh:

Year:  2015        PMID: 26311166     DOI: 10.1038/hr.2015.89

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  28 in total

1.  Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study.

Authors:  Csaba P Kovesdy; Anthony J Bleyer; Miklos Z Molnar; Jennie Z Ma; John J Sim; William C Cushman; L Darryl Quarles; Kamyar Kalantar-Zadeh
Journal:  Ann Intern Med       Date:  2013-08-20       Impact factor: 25.391

Review 2.  Ambulatory blood-pressure monitoring.

Authors:  Thomas G Pickering; Daichi Shimbo; Donald Haas
Journal:  N Engl J Med       Date:  2006-06-01       Impact factor: 91.245

3.  Prediction of the actual awake and asleep blood pressures by various methods of 24 h pressure analysis.

Authors:  R Fagard; J Brguljan; L Thijs; J Staessen
Journal:  J Hypertens       Date:  1996-05       Impact factor: 4.844

4.  Clinical correlates of ambulatory BP monitoring among patients with CKD.

Authors:  Satoshi Iimuro; Enyu Imai; Tsuyoshi Watanabe; Kosaku Nitta; Tadao Akizawa; Seiichi Matsuo; Hirofumi Makino; Yasuo Ohashi; Akira Hishida
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-14       Impact factor: 8.237

Review 5.  The role of ambulatory blood pressure monitoring in chronic and end-stage renal disease.

Authors:  A M Thompson; T G Pickering
Journal:  Kidney Int       Date:  2006-07-19       Impact factor: 10.612

6.  Autonomic dysfunction and urinary albumin excretion rate are associated with an abnormal blood pressure pattern in normotensive normoalbuminuric type 1 diabetic patients.

Authors:  M Pecis; M J Azevedo; R S Moraes; E L Ferlin; J L Gross
Journal:  Diabetes Care       Date:  2000-07       Impact factor: 19.112

7.  Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.

Authors:  Takayoshi Ohkubo; Masahiro Kikuya; Hirohito Metoki; Kei Asayama; Taku Obara; Junichiro Hashimoto; Kazuhito Totsune; Haruhisa Hoshi; Hiroshi Satoh; Yutaka Imai
Journal:  J Am Coll Cardiol       Date:  2005-08-02       Impact factor: 24.094

8.  Morning rise in blood pressure is a predictor of left ventricular hypertrophy in treated hypertensive patients.

Authors:  Toshio Ikeda; Tomoko Gomi; Yuko Shibuya; Kiyoko Matsuo; Takeshi Kosugi; Nami Oku; Yuzaburo Uetake; Satoshi Kinugasa; Rie Furutera
Journal:  Hypertens Res       Date:  2004-12       Impact factor: 3.872

9.  Association between the morning-evening difference in home blood pressure and cardiac damage in untreated hypertensive patients.

Authors:  Yoshio Matsui; Kazuo Eguchi; Seiichi Shibasaki; Motohiro Shimizu; Joji Ishikawa; Kazuyuki Shimada; Kazuomi Kario
Journal:  J Hypertens       Date:  2009-04       Impact factor: 4.844

10.  Diurnal variation of endothelial function and arterial stiffness in hypertension.

Authors:  G E Kollias; K S Stamatelopoulos; T G Papaioannou; N A Zakopoulos; M Alevizaki; G P Alexopoulos; D A Kontoyannis; H Karga; E Koroboki; J P Lekakis; C M Papamichael
Journal:  J Hum Hypertens       Date:  2009-02-26       Impact factor: 3.012

View more
  10 in total

1.  Circadian blood pressure rhythm as a possible key target of SGLT2 inhibitors used for the treatment of Type 2 diabetes.

Authors:  Kouichi Tamura; Hiromichi Wakui; Kengo Azushima; Kazushi Uneda; Satoshi Umemura
Journal:  Hypertens Res       Date:  2016-01-28       Impact factor: 3.872

2.  The deadly line linking sympathetic overdrive, dipping status and vascular risk: critical appraisal and therapeutic implications.

Authors:  Francesca Santilli; Paola Simeone; Damiano D'Ardes; Giovanni Davì
Journal:  Hypertens Res       Date:  2016-03-17       Impact factor: 3.872

3.  The effects of missed doses of amlodipine and losartan on blood pressure in older hypertensive patients.

Authors:  Peter W de Leeuw; Robert Fagard; Abraham A Kroon
Journal:  Hypertens Res       Date:  2017-01-19       Impact factor: 3.872

4.  Association of Nighttime Masked Uncontrolled Hypertension With Left Ventricular Hypertrophy and Kidney Function Among Patients with Chronic Kidney Disease Not Receiving Dialysis.

Authors:  Xiaocen Fu; Hong Ren; Jingyuan Xie; Weiming Wang; Yan Li; Pingjin Gao; Nan Chen
Journal:  JAMA Netw Open       Date:  2022-05-02

5.  Association of Morning Hypertension Subtype With Vascular Target Organ Damage and Central Hemodynamics.

Authors:  Jaewon Oh; Chan Joo Lee; In-Cheol Kim; Sang-Hak Lee; Seok-Min Kang; Donghoon Choi; Sungha Park; Kazuomi Kario
Journal:  J Am Heart Assoc       Date:  2017-02-14       Impact factor: 5.501

6.  Loss of nighttime blood pressure dipping as a risk factor for coronary artery calcification in nondialysis chronic kidney disease.

Authors:  Hoon Young Choi; Chan Joo Lee; Jung Eun Lee; Hyun Su Yang; Ha Yan Kim; Hyeong Cheon Park; Hyeon Chang Kim; Hyuk-Jae Chang; Sung-Ha Park; Beom Seok Kim
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

Review 7.  Clinical features and therapeutic perspectives on hypertension in diabetics.

Authors:  Shigehiro Katayama; Masako Hatano; Masashi Issiki
Journal:  Hypertens Res       Date:  2018-02-05       Impact factor: 3.872

8.  γ Peptide Nucleic Acid-Based miR-122 Inhibition Rescues Vascular Endothelial Dysfunction in Mice Fed a High-Fat Diet.

Authors:  Ravinder Reddy Gaddam; Karishma Dhuri; Young-Rae Kim; Julia S Jacobs; Vikas Kumar; Qiuxia Li; Kaikobad Irani; Raman Bahal; Ajit Vikram
Journal:  J Med Chem       Date:  2022-02-08       Impact factor: 7.446

Review 9.  Management of morning hypertension: a consensus statement of an Asian expert panel.

Authors:  Ji-Guang Wang; Kazuomi Kario; Chen-Huan Chen; Jeong-Bae Park; Satoshi Hoshide; Yong Huo; Hae-Young Lee; Yan Li; Masaki Mogi; Masanori Munakata; Sungha Park; Dingliang Zhu
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-16       Impact factor: 3.738

Review 10.  Circadian variations of vasoconstriction and blood pressure in physiology and diabetes.

Authors:  Tianfei Hou; Zhenheng Guo; Ming C Gong
Journal:  Curr Opin Pharmacol       Date:  2021-03-12       Impact factor: 5.547

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.